Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia
about
Declines in traditional marine food intake and vitamin D levels from the 1960s to present in young Alaska Native women.Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.Vancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection.Functional gene variants of CYP3A4.Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.Evaluation of vitamin D levels in Indian children with intrathoracic tuberculosisSunlight exposure is just one of the factors which influence vitamin D status.Polymorphic Human Sulfotransferase 2A1 Mediates the Formation of 25-Hydroxyvitamin D3-3-O-sulfate, A Major Circulating Vitamin D Metabolite in Humans.Ancestry-Adjusted Vitamin D Metabolite Concentrations in Association with Cytochrome 3A (CYP3A) Polymorphisms.CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.
P2860
Q30151883-A5C59EBE-31E1-4024-BD2F-7D948DCC92B9Q33610642-F6681C8A-CA1D-477E-BEA0-492F178D277DQ37263918-256D4211-D8CA-48C0-B66F-8EFADD5E04A4Q38220008-06204BFD-9553-48A7-8288-613B1B5E7C5BQ41640652-D9C2F8F3-8668-452E-93FF-16B3894E87E1Q42416797-5196ABB0-42C9-472D-91D7-065027590B6AQ47582208-C53C1983-B058-490E-B02C-A629A1661D62Q49989942-F960B1F8-4671-4915-985E-BA511197AA3AQ50548159-94F0387F-CED7-4DDE-9390-C2C08020BA31Q51092138-0FC48408-D0E1-4D77-A93A-4EB6F6DD98A0
P2860
Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Enhancement of hepatic 4-hydro ...... for drug-induced osteomalacia
@ast
Enhancement of hepatic 4-hydro ...... for drug-induced osteomalacia
@en
type
label
Enhancement of hepatic 4-hydro ...... for drug-induced osteomalacia
@ast
Enhancement of hepatic 4-hydro ...... for drug-induced osteomalacia
@en
prefLabel
Enhancement of hepatic 4-hydro ...... for drug-induced osteomalacia
@ast
Enhancement of hepatic 4-hydro ...... for drug-induced osteomalacia
@en
P2093
P2860
P356
P1476
Enhancement of hepatic 4-hydro ...... for drug-induced osteomalacia
@en
P2093
Connie L Davis
Danny D Shen
David L Eaton
Emma-Jane Poulton
Johanna W Lampe
Kenneth E Thummel
Leslie J Dickmann
Margaret C Shuhart
Yvonne S Lin
Zhican Wang
P2860
P304
P356
10.1002/JBMR.1839
P577
2013-05-01T00:00:00Z